Skip Navigation
NIH

The National Human Genome Research Institute conducts genetic and genomic research, funds genetic and genomic research and promotes that research to advance genomics in health care.

Highlights

Chemotherapy Ward Co-presence Network

Social interaction affects cancer patients' response to treatment

Cancer patients were a little more likely to survive for five years or more after chemotherapy if they interacted during chemotherapy with other patients who also survived for five years or more, according to a new study by researchers at the National Human Genome Research Institute, part of the National Institutes of Health, and the University of Oxford in the United Kingdom. The findings were published online July 12, 2017, in the journal Network Science.

Dr. Eric Green

The NHGRI Extramural Grant Portfolio: Using Different Approaches to Fund Genomics Research

In the July issue of The Genomics Landscape, NHGRI Director Eric Green discusses the different approaches NHGRI uses to fund genomics research, among them RFAs and PAs to guide extramural applicants relative to the institute's programmatic interests, and managed consortia that bring together investigators to tackle large research problems. There's also information about the new NCI director, the expansion of the G2C2 website and an educational workshop on Henrietta Lacks.

Eczema

Study examines microbial role in childhood eczema

NHGRI and NCI researchers are probing microbes - bacteria, fungi and viruses - to understand their role in childhood eczema. Using metagenomic sequencing analyses - a powerful sequencing approach that provides insight into microbial biodiversity and function - Julie Segre, Ph.D. (NHGRI), Heidi Kong, M.D., (NCI), and colleagues, pinpointed the presence of unique strains of Staphylococcus aureus in patients with severe eczema and mixed strains of Staphylococcus epidermidis in all individuals. The study was published July 5, 2017, in Science Translational Medicine.

Fusion of Myoblast Cells

NIH and collaborators identify the genomic cause for Carey-Fineman-Ziter syndrome

An international team of researchers has identified the genomic mutations for Carey-Fineman-Ziter (CFZS) syndrome, a very rare, inherited muscle disorder. Their findings provide insight into the development of an embryo's muscles and the regeneration of muscle cells after injury. The study was published today July 6, 2017 in Nature Communications.

Genome: Unlocking Life's Code Exhibit

In the Houston area? Visit our traveling exhibit!

Genome: Unlocking Life's Code, our museum exhibit created with the Smithsonian National Museum of Natural History, and designed for a cross-country tour, is heading south to Houston! It will visit The Health Museum from June 12-September 11, 2017. The exhibit began its journey in Washington, D.C. and was constructed to be disassembled and transported to museums and science centers across the United States. Traveling on a five-year, multi-city tour, this fascinating exhibit challenges visitors to explore the wonderful world of genome science through high-tech, hands-on learning.




Email Updates


Genomics News


Quick Links